Etiometry Platform vs PERISCOPE

Etiometry sells physiologic risk indices to critical care programs. The platform has 11 FDA 510(k) records, from March 2015 to April 2026, and K254066 in April 2026 is a Cardiogenic Shock Tool. The vendor also states a CE Mark under EU MDR. None of its four indices scores infection risk, so the two products serve different units.

A surgical department that wants 7-day and 30-day postoperative infection risk from EHR data would evaluate PERISCOPE. The vendor states a Class IIa CE mark under EU MDR and claims no FDA status, and funding coverage names FDA clearance as a goal. Deventer Ziekenhuis and Amsterdam UMC supply testimonials on its homepage. The Lancet Regional Health Europe study covered 253,010 procedures in Dutch and Belgian hospitals, with 30-day AUROC of 0.82 to 0.91 on 2022-2023 temporal validation after updating. It was retrospective, and two authors work at Healthplus.ai.